Natixis Takes $541,000 Position in iRhythm Technologies, Inc. (NASDAQ:IRTC)

Natixis acquired a new position in shares of iRhythm Technologies, Inc. (NASDAQ:IRTC - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 6,000 shares of the company's stock, valued at approximately $541,000.

A number of other institutional investors have also modified their holdings of the company. Barclays PLC boosted its position in iRhythm Technologies by 34.3% in the 3rd quarter. Barclays PLC now owns 209,247 shares of the company's stock valued at $15,534,000 after buying an additional 53,498 shares during the period. Stephens Investment Management Group LLC boosted its holdings in iRhythm Technologies by 25.6% in the fourth quarter. Stephens Investment Management Group LLC now owns 502,925 shares of the company's stock valued at $45,349,000 after purchasing an additional 102,600 shares during the period. Allspring Global Investments Holdings LLC grew its stake in iRhythm Technologies by 9.6% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 570,048 shares of the company's stock worth $50,991,000 after purchasing an additional 50,075 shares in the last quarter. KBC Group NV increased its holdings in iRhythm Technologies by 45.1% during the 4th quarter. KBC Group NV now owns 1,319 shares of the company's stock worth $119,000 after purchasing an additional 410 shares during the period. Finally, Bank of New York Mellon Corp raised its position in iRhythm Technologies by 23.2% in the 4th quarter. Bank of New York Mellon Corp now owns 491,485 shares of the company's stock valued at $44,317,000 after purchasing an additional 92,591 shares in the last quarter.

iRhythm Technologies Stock Performance

Shares of NASDAQ IRTC traded up $0.65 during midday trading on Monday, reaching $106.64. 331,516 shares of the company were exchanged, compared to its average volume of 458,386. The stock has a market cap of $3.40 billion, a P/E ratio of -29.30 and a beta of 1.45. iRhythm Technologies, Inc. has a 1 year low of $55.92 and a 1 year high of $128.52. The stock has a fifty day simple moving average of $104.48 and a 200 day simple moving average of $95.09. The company has a current ratio of 6.27, a quick ratio of 6.12 and a debt-to-equity ratio of 9.00.

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last released its earnings results on Thursday, February 20th. The company reported $0.01 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.29) by $0.30. iRhythm Technologies had a negative return on equity of 118.83% and a negative net margin of 19.14%. The business had revenue of $164.33 million for the quarter, compared to analyst estimates of $158.30 million. On average, research analysts forecast that iRhythm Technologies, Inc. will post -1.98 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

IRTC has been the subject of a number of analyst reports. Needham & Company LLC boosted their target price on shares of iRhythm Technologies from $125.00 to $138.00 and gave the stock a "buy" rating in a research note on Friday, February 21st. Oppenheimer upped their price objective on iRhythm Technologies from $105.00 to $120.00 and gave the stock an "outperform" rating in a research report on Wednesday, January 8th. The Goldman Sachs Group increased their price objective on iRhythm Technologies from $91.00 to $124.00 and gave the company a "neutral" rating in a report on Monday, February 24th. StockNews.com raised iRhythm Technologies from a "sell" rating to a "hold" rating in a report on Monday, February 24th. Finally, Wells Fargo & Company raised their price objective on shares of iRhythm Technologies from $86.00 to $104.00 and gave the stock an "equal weight" rating in a report on Friday, February 21st. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $119.73.

About iRhythm Technologies

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.